Immunohistochemical analysis showed that MIF expression was ~2-fold higher, LC3 expression increased significantly by ~4-fold and STAT3 phosphorylation was 1.5-fold higher in ConA-treated tumor lesions compared with the control groups (Figure 7). The gene discussed is STAT3; the disease is neoplasm.